TW592705B - Liquid composition for oral use containing calcium component and acidulant and method of reducing tooth erosion property of acidic oral composition - Google Patents
Liquid composition for oral use containing calcium component and acidulant and method of reducing tooth erosion property of acidic oral composition Download PDFInfo
- Publication number
- TW592705B TW592705B TW086103057A TW86103057A TW592705B TW 592705 B TW592705 B TW 592705B TW 086103057 A TW086103057 A TW 086103057A TW 86103057 A TW86103057 A TW 86103057A TW 592705 B TW592705 B TW 592705B
- Authority
- TW
- Taiwan
- Prior art keywords
- composition
- calcium
- acid
- patent application
- scope
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 67
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 title claims abstract description 57
- 239000011575 calcium Substances 0.000 title claims abstract description 57
- 229910052791 calcium Inorganic materials 0.000 title claims abstract description 57
- 230000002378 acidificating effect Effects 0.000 title claims abstract description 23
- 206010044038 Tooth erosion Diseases 0.000 title claims abstract description 5
- 238000000034 method Methods 0.000 title claims description 18
- 239000007788 liquid Substances 0.000 title claims description 12
- 208000036595 non-bacterial tooth erosion Diseases 0.000 title abstract 2
- 239000002253 acid Substances 0.000 claims abstract description 60
- 235000013361 beverage Nutrition 0.000 claims abstract description 44
- 239000012141 concentrate Substances 0.000 claims abstract description 17
- 229940043430 calcium compound Drugs 0.000 claims abstract description 10
- 150000001674 calcium compounds Chemical class 0.000 claims abstract description 10
- 235000015203 fruit juice Nutrition 0.000 claims abstract description 5
- 239000002324 mouth wash Substances 0.000 claims abstract description 5
- 229960005069 calcium Drugs 0.000 claims description 55
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 54
- 235000008504 concentrate Nutrition 0.000 claims description 20
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 claims description 13
- 239000000920 calcium hydroxide Substances 0.000 claims description 13
- 229910001861 calcium hydroxide Inorganic materials 0.000 claims description 13
- 235000011116 calcium hydroxide Nutrition 0.000 claims description 13
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 8
- 230000036541 health Effects 0.000 claims description 7
- 235000013399 edible fruits Nutrition 0.000 claims description 6
- 239000002535 acidifier Substances 0.000 claims description 4
- 239000004310 lactic acid Substances 0.000 claims description 4
- 235000014655 lactic acid Nutrition 0.000 claims description 4
- 239000002689 soil Substances 0.000 claims description 4
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 claims description 3
- 239000001354 calcium citrate Substances 0.000 claims description 3
- 229940051866 mouthwash Drugs 0.000 claims description 3
- 235000013337 tricalcium citrate Nutrition 0.000 claims description 3
- CBOCVOKPQGJKKJ-UHFFFAOYSA-L Calcium formate Chemical compound [Ca+2].[O-]C=O.[O-]C=O CBOCVOKPQGJKKJ-UHFFFAOYSA-L 0.000 claims description 2
- 229960004256 calcium citrate Drugs 0.000 claims description 2
- 235000019255 calcium formate Nutrition 0.000 claims description 2
- 239000004281 calcium formate Substances 0.000 claims description 2
- 229940044172 calcium formate Drugs 0.000 claims description 2
- OLOZVPHKXALCRI-UHFFFAOYSA-L calcium malate Chemical compound [Ca+2].[O-]C(=O)C(O)CC([O-])=O OLOZVPHKXALCRI-UHFFFAOYSA-L 0.000 claims description 2
- 239000001362 calcium malate Substances 0.000 claims description 2
- 229940016114 calcium malate Drugs 0.000 claims description 2
- 235000011038 calcium malates Nutrition 0.000 claims description 2
- IWIRHXNCFWGFJE-UHFFFAOYSA-L calcium;2,3-dihydroxypropyl phosphate Chemical compound [Ca+2].OCC(O)COP([O-])([O-])=O IWIRHXNCFWGFJE-UHFFFAOYSA-L 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 235000021559 Fruit Juice Concentrate Nutrition 0.000 claims 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- 235000001537 Ribes X gardonianum Nutrition 0.000 claims 1
- 235000001535 Ribes X utile Nutrition 0.000 claims 1
- 235000016919 Ribes petraeum Nutrition 0.000 claims 1
- 244000281247 Ribes rubrum Species 0.000 claims 1
- 235000002355 Ribes spicatum Nutrition 0.000 claims 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims 1
- 229940095643 calcium hydroxide Drugs 0.000 claims 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims 1
- 239000001527 calcium lactate Substances 0.000 claims 1
- 229960002401 calcium lactate Drugs 0.000 claims 1
- 235000011086 calcium lactate Nutrition 0.000 claims 1
- 239000000460 chlorine Substances 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 229940060038 chlorine Drugs 0.000 claims 1
- 235000017168 chlorine Nutrition 0.000 claims 1
- 235000014058 juice drink Nutrition 0.000 claims 1
- XYFCBTPGUUZFHI-UHFFFAOYSA-O phosphonium Chemical compound [PH4+] XYFCBTPGUUZFHI-UHFFFAOYSA-O 0.000 claims 1
- 239000010948 rhodium Substances 0.000 claims 1
- 229910052703 rhodium Inorganic materials 0.000 claims 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 claims 1
- 239000011975 tartaric acid Substances 0.000 claims 1
- 235000002906 tartaric acid Nutrition 0.000 claims 1
- 239000003513 alkali Substances 0.000 abstract description 8
- 230000002829 reductive effect Effects 0.000 abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 27
- 229960004106 citric acid Drugs 0.000 description 17
- 239000004615 ingredient Substances 0.000 description 17
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 16
- 210000003298 dental enamel Anatomy 0.000 description 16
- 235000013949 black currant juice Nutrition 0.000 description 14
- 238000012360 testing method Methods 0.000 description 14
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 11
- 238000002156 mixing Methods 0.000 description 11
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 10
- 239000001630 malic acid Substances 0.000 description 10
- 235000011090 malic acid Nutrition 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 238000011282 treatment Methods 0.000 description 9
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 8
- 235000010323 ascorbic acid Nutrition 0.000 description 8
- 239000011668 ascorbic acid Substances 0.000 description 8
- 229960005070 ascorbic acid Drugs 0.000 description 8
- 230000035622 drinking Effects 0.000 description 8
- 230000007797 corrosion Effects 0.000 description 7
- 238000005260 corrosion Methods 0.000 description 7
- 239000002585 base Substances 0.000 description 6
- 235000015205 orange juice Nutrition 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 150000007513 acids Chemical class 0.000 description 5
- 230000002079 cooperative effect Effects 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 4
- 108010011485 Aspartame Proteins 0.000 description 4
- 239000000619 acesulfame-K Substances 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 239000000605 aspartame Substances 0.000 description 4
- 235000010357 aspartame Nutrition 0.000 description 4
- 229960003438 aspartame Drugs 0.000 description 4
- 229910000019 calcium carbonate Inorganic materials 0.000 description 4
- 159000000007 calcium salts Chemical class 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 208000002925 dental caries Diseases 0.000 description 4
- 239000006188 syrup Substances 0.000 description 4
- 235000020357 syrup Nutrition 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 3
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- 210000004268 dentin Anatomy 0.000 description 3
- 230000003628 erosive effect Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 3
- 150000003839 salts Chemical group 0.000 description 3
- 239000002002 slurry Substances 0.000 description 3
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 3
- 239000004299 sodium benzoate Substances 0.000 description 3
- 235000010234 sodium benzoate Nutrition 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 229910000831 Steel Inorganic materials 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 235000015197 apple juice Nutrition 0.000 description 2
- 235000009582 asparagine Nutrition 0.000 description 2
- 229960001230 asparagine Drugs 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229960002713 calcium chloride Drugs 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 2
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 229940001584 sodium metabisulfite Drugs 0.000 description 2
- 235000010262 sodium metabisulphite Nutrition 0.000 description 2
- 239000010959 steel Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- LYUQWQRTDLVQGA-UHFFFAOYSA-N 3-phenylpropylamine Chemical compound NCCCC1=CC=CC=C1 LYUQWQRTDLVQGA-UHFFFAOYSA-N 0.000 description 1
- PXRKCOCTEMYUEG-UHFFFAOYSA-N 5-aminoisoindole-1,3-dione Chemical compound NC1=CC=C2C(=O)NC(=O)C2=C1 PXRKCOCTEMYUEG-UHFFFAOYSA-N 0.000 description 1
- 240000005528 Arctium lappa Species 0.000 description 1
- 235000003130 Arctium lappa Nutrition 0.000 description 1
- 235000008078 Arctium minus Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- IMUWTNUSPXFXJN-UHFFFAOYSA-K C(=O)=O.[OH-].[Na+].C([O-])([O-])=O.[Ca+2] Chemical compound C(=O)=O.[OH-].[Na+].C([O-])([O-])=O.[Ca+2] IMUWTNUSPXFXJN-UHFFFAOYSA-K 0.000 description 1
- YTTKLQZKMYRMAP-UHFFFAOYSA-M C(C=CC=CC)(=O)[O-].[K+].C(C(O)C)(=O)O Chemical compound C(C=CC=CC)(=O)[O-].[K+].C(C(O)C)(=O)O YTTKLQZKMYRMAP-UHFFFAOYSA-M 0.000 description 1
- LUIVXMPWEIYFPR-UHFFFAOYSA-N CN(C)C.O=C1OC1 Chemical compound CN(C)C.O=C1OC1 LUIVXMPWEIYFPR-UHFFFAOYSA-N 0.000 description 1
- 101100256965 Caenorhabditis elegans sip-1 gene Proteins 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- YASYEJJMZJALEJ-UHFFFAOYSA-N Citric acid monohydrate Chemical compound O.OC(=O)CC(O)(C(O)=O)CC(O)=O YASYEJJMZJALEJ-UHFFFAOYSA-N 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 240000004307 Citrus medica Species 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 240000001890 Ribes hudsonianum Species 0.000 description 1
- 235000016954 Ribes hudsonianum Nutrition 0.000 description 1
- 235000001466 Ribes nigrum Nutrition 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- YGCFIWIQZPHFLU-UHFFFAOYSA-N acesulfame Chemical compound CC1=CC(=O)NS(=O)(=O)O1 YGCFIWIQZPHFLU-UHFFFAOYSA-N 0.000 description 1
- 229960005164 acesulfame Drugs 0.000 description 1
- KQNKJJBFUFKYFX-UHFFFAOYSA-N acetic acid;trihydrate Chemical compound O.O.O.CC(O)=O KQNKJJBFUFKYFX-UHFFFAOYSA-N 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 235000016127 added sugars Nutrition 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 239000008122 artificial sweetener Substances 0.000 description 1
- 235000021311 artificial sweeteners Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- LLSDKQJKOVVTOJ-UHFFFAOYSA-L calcium chloride dihydrate Chemical compound O.O.[Cl-].[Cl-].[Ca+2] LLSDKQJKOVVTOJ-UHFFFAOYSA-L 0.000 description 1
- 229940052299 calcium chloride dihydrate Drugs 0.000 description 1
- 229940092124 calcium citrate malate Drugs 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 229940087373 calcium oxide Drugs 0.000 description 1
- 235000012255 calcium oxide Nutrition 0.000 description 1
- MPCMQXRREZMSPJ-UHFFFAOYSA-L calcium;2-hydroxybutanedioate;2-hydroxypropane-1,2,3-tricarboxylic acid;pentahydrate Chemical compound O.O.O.O.O.[Ca+2].[O-]C(=O)C(O)CC([O-])=O.OC(=O)CC(O)(C(O)=O)CC(O)=O MPCMQXRREZMSPJ-UHFFFAOYSA-L 0.000 description 1
- 238000009924 canning Methods 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- 229960002303 citric acid monohydrate Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000021557 concentrated beverage Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 239000008233 hard water Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- DWKPPFQULDPWHX-VKHMYHEASA-N l-alanyl ester Chemical compound COC(=O)[C@H](C)N DWKPPFQULDPWHX-VKHMYHEASA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 235000008729 phenylalanine Nutrition 0.000 description 1
- 229960005190 phenylalanine Drugs 0.000 description 1
- 125000004344 phenylpropyl group Chemical group 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 235000021573 pickled cucumbers Nutrition 0.000 description 1
- 229940043349 potassium metabisulfite Drugs 0.000 description 1
- 235000010263 potassium metabisulphite Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- UJMBCXLDXJUMFB-GLCFPVLVSA-K tartrazine Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-GLCFPVLVSA-K 0.000 description 1
- 229960000943 tartrazine Drugs 0.000 description 1
- 239000004149 tartrazine Substances 0.000 description 1
- 235000012756 tartrazine Nutrition 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- -1 trimethylammonium lactone Chemical class 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 230000001755 vocal effect Effects 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/68—Acidifying substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Inorganic Chemistry (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Mycology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Non-Alcoholic Beverages (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Description
592705 A7 B7 五、發明説明。~ 一 — 人:發::闞:口服組合物,例如酸性飲料和口服保健組 口 在藏寺組合物中使用鈣來減輕或預防與食用酸有 關之牙齒損害。本發明尤其會緩和與飲料中添 味道問題。 π關< 、·特別由酸性食品所引起的牙齒齒質腐蝕而使牙齒中 溶解出的速度咸信會比正常再形成礦物質過程中的置換速 度快。當根據本發明製備一種產品如飲科,並且爲了飲用 或保健目的而倒入口腔時,以化學方法溶解或移除料 鈣和磷酸鹽會明顯減少。 鈣疋體内取豐富的礦物質。大部份的鈣儲存於骨頭和牙 齒内,但礦物質對其它身體功能,例如調節神經作用、肌 肉收縮和血液凝固也是必需的。鈣是由水果成份和未先經 過軟化而使用於飲料製造中的硬水所衍£之—常見岛飲料^ 成物。典型上以此方法存在的鈣濃度値範園爲重量比 0.005-0.02%。由於對於藉由鈣離子加強飲食營養價値的一 般營養之好處有興趣,因此需要尋找一種實行方法將此離 子以較高的重量比0.02 %至2%加入飲料内。鈣做爲飲料 添加物的用途已敘述於WO88/03762中。 經濟部中央標準局員工消費合作社印製 添加蘋果酸有助於利用以鈣加強飲食營養價値之飲料中 維持鈣的溶解度已廣爲人知,因此可將因沉澱所引起的損 失減到最小。這是因爲可溶解的複合物「鈣檸檬酸蘋果酸 鹽」的形成。另一方面,Lussi等人(1995,Caries Res 29,349-354)已提出飲料之可滴定酸度與其齒質腐蝕之可能 性有關;飲料中的酸濃度愈大,則其對牙齒的損害就愈 -4 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 592705 Α7 Β7 經濟部中央標準局員工消費合作社印製 五、發明説明(2 ) 大。 在PCT US 91/07117中揭示一種藉由飲用含有檸檬酸對蘋 果酸之莫耳比率呈I··0·5至1:4.5之躬檸檬酸蘋果酸鹽複 合物形悲,且鈣的重量比爲〇 〇 2 %至〇 · i 5 %之酸性飲料 (酸鹼値低於5·5)以預防牙齒琺瑯質腐蝕之方法。在鈣檸 樣酸韻果酸鹽複合物中,鈣對鈣檸檬酸及蘋果酸之總莫耳 數的莫耳比率可以是約2:1:1至約6:3:4。供飲料使用之 較佳複合物的莫耳比率爲4 : 2 : 3。 我們已發現飲料含有高量的鈣會產生味道的問題。本發 明係根據以下發現,當也控制組合物之酸鹼値時,較酸化 劑低量的鈣可以達到使酸性口服組合物有效減少牙齒齒質 腐餘之效果。 本發明一方面係提供一種含有鈣化合物及-酸化如特性供 口服用的液態組合物,其中每莫耳酸中所存在之鈣的範圍 爲0.3至0.8莫耳,而且在組合物中所選用之鈣和酸化劑 的量會使待該組合物之酸驗値呈35至4.5。 本發明另一方面係提供以鈣做爲牙齒齒質腐蝕抑制劑之 口服酸性組合物的用途,藉由添加鈣化合物至該組合物中 使得每莫耳酸中所存在之鈣的範圍爲〇.3至〇.8莫耳,而 且在組合物中所選用之鈣和酸化劑的量會使得該組合物之 酸驗値呈3.5至4.5。 本發明還有一方面係提供一種可減少牙齒齒質腐蝕之酸 性口服組合物的方法,其中包括添加鈣化合物至該酸性液 悲口服組合物内,使得每莫耳酸中所存在之鈣的範圍爲 -5- 本紙張尺度適用中g國家標準(CNS ) Α4規格(2丨〇><297公釐) (請先閱讀背面之注意事項再填寫本頁) :裝. -m 592705 A7 B7 五、發明説明(: 3至〇·8莫耳,而若有需要或必要下,藉由添加鹼調整 酸驗値使得該組合物之酸鹼値介於3 5至4 · 5間。
請 先 閱 1讀 背 之 注 意 事 項 II I f 頁I 本發明仍有一方面係提供一種製備本發明之組合物的方 法,其中包括添加鈣化合物至酸性液態口服組合物内,使 得每莫耳酸中所存在之鈣的範圍爲0.3至〇·8莫耳,而若 有需要或必要下,則藉由添加鹼調整酸鹼値使得該組合物 之酸驗値介於3.5至4.5間。 本發明可應用於供飲用之水溶性酸性物質,例如酸性飲 料、果汁、西打、酒、醋和醃黃瓜及各種酸性乳製品,並 且也可應用於供飲用之其它液態物質,例如酸性漱口水及 藥物。 訂 實地應用本發明不會使飲料的味道產生缺陷。雖然飲料 的酸鹼値增加到約4時,當然會減少酸〜化劑所‘成的異 味,但令人驚訝的是根據本發明之鈣内含物卻可以缓和此 味道。 使用根據本發明之鹼鹽型態之低量鈣會有另一種好處。 配方之缓衝能力因酸的部份中和作用而降低,因而使得口 中的唾液可以更快速地中和殘餘物。 經濟部中央標準局員工消費合作社印製 本發明中所使用的鈣絕對濃度會根據所存在之酸的性質 和k度而改變,因此並不重要。酸性溶液可以含有有機和 /或無機酸,並且可以添加維生素,如壞血酸。在濃縮飲 料中,飲用前須先以5倍的水稀釋,鈣濃度會在每升〇〇〇1 莫耳至每弁0:05莫耳以上間變動。易開罐飲料中的鈣濃 度變化爲每升0.0002莫耳至每升〇.〇1莫耳以上。 -6· 本紙張尺度適财關家鮮(CNS ) A4規格(2IQx2^^-y 592705 經濟部中央標準局員工消費合作社印製 A7 B7 五、發明説明(4 ) ~- #5可以以任何簡單的鹽型態添加,如碳酸舞、气氧化 鈣、檸檬酸鈣、蘋果酸鈣、氯化鈣、甘油磷酸鈣或甲酸鈣 或任何其它的鹽,以使食用時所產生之任何不佳味道減到 最低。 本發明也可藉由混合酸(如檸檬酸)與其相對應的鈣鹽 (如擰檬酸躬)或另外的鈣鹽而宋成。在配方中,混合酸與 鹼性鈣鹽,如碳酸鈣或氫氧化鈣有利於使酸的濃度減到最 小。該酸也可以與無機鈣,如氯化鈣混合。 鈣對酸的莫耳比率可以是03-〇75,較典型爲〇3-0.65,而較佺爲0.3-0.55。最好莫耳比率至少爲〇4, 而據發現約0 · 5的數値尤其有效。 藉由添加適當比例的鈣化合物至酸中可以調整配方的酸 鹼値至所需的範圍内。若有需要時,依〜據蛴存在的酸不 同,可以利用鹼,如氫氧化鈉或適宜的鹽,如檸檬酸鈉, 蘋果酸銷或乳酸鋼進一步調整酸驗値。 組合物的酸鹼値最好不要高於4,從3.7至3.9最佳。據 發現酸驗値約3 · 8的組合物尤其有效。 濃縮果汁飲料中典型的檸檬酸或蘋果酸濃度範圍爲重量 百分比0 · 1 %至4 %。易開罐飲料中,酸的濃度典型上範圍 爲重量百分比0 · 0 1 %至1 %。傳統上供飲料用之傳統其它 可食酸,例如乳酸也可使用。亦可使用可食酸之混合物。 在較佳具體例中,酸性組合物是由天然果汁,如黑醋栗 汁所製備的飲料濃縮物,例如有香味的糖漿濃縮物。尤其 當飲料是以飲用前需先稀釋之濃縮物賣給消費者,或當稀一 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閲讀背面之注意事項再填寫本頁) ^衣· -5 观705 經濟部中央標準局員工消費合作社印製 A7 五、發明説明(5 ) "-— 釋糖裝濃縮物以製備「易開罐」稀釋後之濃縮物時,可以 添加適宜型態的鈣至該濃縮物内。最好該產品含有減量的 糖或碳水化合物’或爲含有強烈增甜劑之低卡路里型態。 口服組合物可以含有鎂或其它離子做爲再礦化作用之添 加劑。口服組合物也可以含有有效量之蘋果酸或其可食用 ,來維持鈣的溶解度,以使得預防或不溶的鈣鹽沉澱減到 最少。所添加的蘋果酸僅佔飲料總酸度中少量的〗〇 %, 剩餘的酸度則由其它的酸提供,最好爲天然存在的酸,如 檸檬酸或抗壞血酸。 本發明可以應用於一些飲料中,例如濃縮物,不起泡沫 的果汁飲料,或碳酸化清涼飲料,及特別是保健飲料,如 黑醋栗果汁飲料或添加維生素的飲料。本發明應用於含有 天然或添加檸檬酸的飲料尤其有益。該嵌料-可以不加糖或 疋以糖或強烈増甜劑如糖精、天冬胺醯基苯基丙胺醯基曱 酯’或其它本藝中已知之增甜劑增甜。該飲料也含有其它 傳統的添加物,如苯甲酸鈉、山梨酸、焦亞硫酸鈉、抗壞 血酸、香料、色素和二氧化碳。 藉由混合根據傳統方法的成份可以製備出飲料。若有需 要,在添加至其它成份之前,可以先將固態成份溶於水或 熱水中。典型的飲料在裝填入瓶或罐或其它包裝前經低 溫殺菌’或在裝填後整包低溫殺菌。 以下的實施例係説明本發明:_ 實施例1 藉由混合以下的成份後製備一種食用前需先以5倍水稀 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁j -訂- 592705 A7 B7 五、發明説明( 6 釋之濃縮飲料產品。最後將碳酸鈣添加至其它的成份内 經濟部中央標準局員工消費合作社印製 84升 1.15公斤 1.8公斤 0.8公斤 0.325公斤 0.145公斤 0·3升 1000 升 4.2公斤 黑醋栗汁濃縮物 SG 1.27 天冬胺醯基苯基丙胺醯基甲酯* 阿斯撒芬K(Acesulfame Κ) 抗壞血酸 苯甲酸鈉 焦亞硫酸鈉 黑醋栗汁香料 水 碳酸鈣 * 以 Aspartame (RTM)販售 鈣:酸的莫耳比率爲0.5。 以氫氧化鈉溶液將濃縮物之酸鹼値調鲞13.7。在以5 倍份水稀釋該濃縮物時(至飲用程度),發現該組合物之酸 鹼値典型上爲3.85。 在3 7 °C下將平坦的牙齒琺瑯質切面曝露於測試溶液中 3 0分鐘以進行體外測平試驗。藉由物理測量於該步驟間 所損失之琺瑯質深度來評估齒質腐蝕之可能性。本發明之 用途係以含有14毫莫耳檸檬酸,酸鹼値3.2且會導致琺瑯 質損失4微米之控制組配方,和另一種14毫莫耳檸檬酸, 酸鹼値3 . 8 5,可以移除1 . 8微米之控制配方:以及含有1 4 毫莫耳檸檬酸、7毫莫耳鈣,酸粉値3.85,只移除0.17 微米的琺瑯質,經調整酸鹼値並添加鈣之後的測試配方來 示範説明。 加至總量達 9 - 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閱讀背面之注意事項再填寫本頁) 592705 A7 B7 五、發明説明(7 ) 實施例2 藉由混合以下的成份製備易開罐飲料: 成份 糖 苯曱酸鈉 柳橙汁 抗壞血酸 檸檬酸單水化物 香料 色素 水 碳酸鈣 氫氧化鈉 二氧化碳 本飲料中鈣:酸的莫耳比率爲0.46(柳橙汁典型上重量百 分比爲1 %檸檬酸) 實施例3 藉由混合以下的成份製備易開罐飲料: 差 足夠調整酸鹼値至 重量百分比% 10 0.01 5.04 0.03 0.15 0.005 0.004 86 0.048 3:9 " 0.48 (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 成份 糖 苯曱酸鈉 蘋果汁 抗壞血酸 蘋果酸 重量百分比% 8 0.01 10 0.03 0.15 -10- 本紙張尺度適用中國國家標準(CNS ) A4規格(2丨0X297公釐) 592705 A7 B7 五、發明説明(8 ) 香料 0.005 色素 0.004 水 差 82 碳酸鈣 0.093 氫氧化鈉 足夠調整酸鹼値至 3.9 本飲料中鈣:酸.的莫耳比率爲0.74(蘋果汁典型上重量百 分比爲0 · 6 %蘋果酸) 實施例4 體内研究 藉由混合以下成份製造飲料: 黑醋栗汁濃縮物 16.78公升 天冬胺醯基苯基丙胺醯基甲酯* 0.54公斤 阿斯撒芬K(Acesulfame Κ) ~ 0.1Ϊ公斤 抗壞血酸 0.45公斤 香料 0.55公升 氫氧化鈣 0.52公斤 水 加至 1000.00 公升 (請先閱讀背面之注意事項再填寫本頁) ··裝·
、1T 經濟部中央標準局員工消費合作社印製 最後添加與部份水呈漿狀之氫氧化鈣,使得足以製造含有 鈣且鈣對擰檬酸之莫耳比率爲0.5:1之飲料。所生成之飲 料酸鹼値爲3.8。分批快速低溫殺菌並裝入250毫升 「Tetra-Brik」容器。 在此研究中,比較3種飲料與人類琺瑯質之流失:上述實 施例,做爲陽性反應控制組(酸鹼値3 · 8 )之柳橙汁,和做 爲陰性反應控制組之水。 -11 - 本纸張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 义/05 A7 B7 五 '發明説明(9 12位志願者在3個治療法之拉丁方形交又設計中參與本 研究、。每個研究期間爲期3週,每週爲5個工作天。於每 :研究期間,每個工作天於用具上研磨萃取自健康牙齒的 铁螂質切面7小時。觀察在4種漸漸一口 — 口飲用25〇毫升 測試飲料期間的情況1()分鐘。研究對象可以不用該用具 以食用午餐,但當使用該用具時不可食用食物或其它飲 料二在治療期間開始和每個治療週結束時以測平器測定琺 螂貝檢方法之原理已敘述於Davis* (1977)英國 =科雜誌143,116-119中)。所有的判讀皆操作兩次。在 侵蝕期間後,然後每個研究對象開始以新的琺瑯質檢體進 行下個治療。結果顯示於下表中,以微米表示研究對象 座--曝露,間及方法内巧予治療後琺瑯質的損失。 5天 10天 Ϊ5天 0.098 0.153 黑醋栗汁 0.341 0.376 0.166 0.407 經濟部中央標準局員工消費合作社印製 〜果顯7F黑醋栗汁配方所造成的侵蚀性最輕微,只比水 :餘性高,而且明顯地比柳橙汁的侵蝕性低。 實施例5 體外研究 爲了研究瑞瑯質曝露於劈添加物對檸檬酸溶液的重 性,進行5項實驗,每項皆使甩8隻牙齒。首先處理 齒’以鹽水沖洗,然後除了直徑5厘米實驗窗外,覆蓋 酸性阻抗蠟。 0.911 1.459 2.543 的 要 牙 以 -12 - 本紙張尺度適用中國國家標隼(CMS ) A4規格(210X 297公釐) (請先閲讀背面之注意事項再填寫本頁)
592705 A7 B7 10 經濟部中央標準局員工消費合作社印製 五 '發明説明( 在每項實驗中,該牙音以Λ 連终s八於棍& 嵩乂0·1毫升/分鐘的速度接受6次 L,5分鐘曝露於〇 3 %檸 ★、 、 L Λ Λ 豕酸/谷敗。該檸檬酸的溶液添 加 0·0,〇·5,1.5,2 5,5 0,7 < ^ · · 7·5,10或15亳莫耳氫氧化鈣型 悲的鈣,並利用i 〇莫耳 .0 今0氧乳化鈉碉整其酸鹼値3.5或 乂8。牙齒在每5分鐘曝霞接 ]JL ^ 缺说士 嗓路後,收集殘餘的檸檬酸檢體·, 然後在利用Chen等人八a 〇w , ( 6),、刀析化學,第28册,1956- 中的磷分析法前,先將其冷 ------- ------Ί 莫耳比率__ ----- 均量(微克)±1SD (¾莫耳) 鈣:酸 酸鹼値3.5 酸驗値3 8 0 0.00 ----- LlLiMi 1 26 + 0 1 7 0.5 0.03 1.25±〇·ΐ4 1 02 + 0 OQ 1.5 0.10 107 + 0.15 0.83+0 12 2.5 0.17 1·22±〇·ΐ4 0.63 + 0 13 5 0.35 〇·79±〇·〇6 0.46 + 0 13 7.5 0.52 〇·72±〇.ι 0.32 土 〇. i〇 10 0.70 〇·46 土 〇·ΐ3 〇·24 土 〇· 11 15 1.05 ——---- 〇·3 + 0·1〇 〇.14±〇.〇7 ▼一 v ·」/()恃稼酸浴硬以降低其 腐蝕之可能性。直到鈣與酸之莫耳比率達約0 5(大約7 5 毫莫耳飼)時效果取大。在此之前増加約:酸莫耳比率不各 達到明顯降低腐蝕之可能性。 - 9 實施例6 藉由混合以下的成份後,攪拌製備成有香味的濃縮物。 -13· 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) (請先閱讀背面之注意事項再填寫本頁)
592705 A7 B7 五、發明説明) 最後添加溶於冷水中形成漿狀之氫氧化鈣,並用水調整其 容積至1 00 0升。 成份 單位 量 黑醋栗汁濃縮物 升 67.1 增甜劑 公斤 3.33 抗壞血酸 公斤 2.28 防腐劑 公斤 0.045 香料 升 1.2 氫氧化鈣 公斤 2.96 水至1000升 於9 3 °C下將飲料濃縮物瞬間低溫殺菌4 2秒,並充填入 600毫升瓶子内。鈣對檸檬酸的莫耳比率爲0.4,且其最 終酸鹼値爲3.7。 " 一 以5部份水稀釋組合物至可飲用的程度時,其酸鹼値爲 3 . 8 5,而該飲料之香咮則如典型的黑醋栗汁果汁所述。 於室溫和3 0 °C下測試該飲料濃縮物之儲存安定性。在9 個月期間後,未發現有不溶的鈣沉澱。 經濟部中央標準局員工消費合作社印製 (讀先閲讀背面之注意事項再填寫本頁) 實施例7 體内研究 藉由混合以下成份製造飲料: 黑醋栗汁濃縮物 10.07 升 天冬胺醯基苯基丙胺醯基甲酯 0.21公斤 阿斯撒芬K(Acesulfame K) 0.07公斤 抗壞血酸 0.27公斤 -14- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 592705 A7 B7 五、發明説明( 12 經濟部中央標準局員工消費合作社印製 重量百分比80%之乳酸 山梨酸酯鉀 焦亞硫酸鈉 香料 氫氧化鈣 水 加至 最後添加與部份水形成漿狀的氫氧化劈 有鈣對擰檬酸/乳酸之莫耳比率爲〇45:1之鈣的飲料。所 生成的飲料酸驗値爲3.85。將此批配方裝入25〇毫升容 器内,並整批低溫殺菌。 在此研%中,比板4種飲料間之琺瑯質損失:上述實施 例,市售酸驗値爲3.0且未添加鈣之黑醋栗汁,做爲陽性 反應控制組(酸鹼値爲3·9)之柳橙沣,及-做爲陰祛反應控 制組之水。 12位志願者參與本研究。每個研究期間爲期3週,每週 爲5個工作天。於每個研究期間,每個工作天於用且上研 磨萃取自健康牙齒的,質切面7小#。觀察在4種漸漸 一口一 口飲用25 0毫升測試飲料期間的情況1〇分鐘。研究 對象可以不用該用具而進食牛鬈,伯本庇m、、 逆卞卞餐,但當使用該用具時則不 可食用食物或其它飲料。在治瘃名日門aha 杜Μ僚期間開始和每個治療週社 束時,以測平器測量㈣質檢體(方法之原以㈣^ 的判讀皆操作兩次。然後在侵蚀期間後,每個研究 始以新的缺瑯質檢體進行下一個治療。 $ 0.66 升 0.1公斤 0.02公斤 0.56 升 0.52公斤 600.00升 使其足以製造含 (請先閱讀背面之注意事項再填寫本頁) ·装· 訂 本紙張尺度適用中國國家標準(CNS ) -15- 592705 A7 B7 五、發明説明(13 ) 其結果顯示於下表中,在一定的曝露期間經由給予治療 後之琺瑯質損失以微米表示。 15天 水 0.11 黑醋栗汁 0.39 市售之黑醋栗汁 1.44 柳橙汁 1.29 結果顯示黑醋栗汁配方的侵蚀性最小,僅比水的侵蝕性 高,但十分明顯地比柳橙汁或市售之黑醋栗汁飲料的侵蚀 性低。 實施例8 藉由一起混合以下成份製備可樂濃縮物 正亞磷酸SG 1.585 41升- -—— - 檸檬酸 120公斤 咖啡因BP 5.3公斤 可樂乳狀劑 29.25 升 雙強度焦糖 125升 加水至 400升 (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 然後藉由一起混合以下成份製備總共爲1 + 5份之可樂糖漿 天冬胺醯基苯基丙胺醯基甲酯 1.8公斤 可溶性糖精 500克 可樂濃縮物 25升 可樂助促進劑 600毫升 氫氧化#5 3.108公斤 加水至 1000 升 16- 本纸張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) 592705 A7 B7 五、發明説明(14 ) 最後添加與部份水形成漿狀之氫氧化鈣,然後以凌化水稀 釋可樂糖漿,裝罐且整箱低溫殺菌以製造酸鹼値爲3.5, 且鈣對酸莫耳比率爲〇 . 6的最終產物。 實施例9 (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 將乙醇、氯化鯨蠟醇吡啶蟠、天勾(Tego)三甲銨乙内酯 CK-KB5(商標名爲cocamido propyl betaine [柯卡咪朵丙基 三曱铵乙内酉旨])和香料一起混合形成清澈溶液。於另一個 容器内,轉其餘成份一起混合。然後將乙醇溶液加至水溶 性溶液内,以製造酸鹼値爲4.5,且鈣對酸之莫耳比率爲 0.4的漱口水。 實施例1 0 - 藉由混合以下成份製備易開罐飲料: -17- 藉由混合以下成份製備漱口水: 重量百分比% 乙醇9 6 % B P 8 可溶性糖精 0.06 氯化絲壤醇峨淀蟠 0.05 天勾(Tego)三甲銨乙内酯CK-KB5 0.2 香料 0.12 醋酸鋼三水合物 0.05 醋酸80% 0.1575 氯化鈣二水合物 0.123 去離子水 91.24 本纸張尺度適用中國國家標準(CNS ) A4規格(210X:297公釐) 592705 經濟部中央標準局員工消費合作社印製 成份 重量百分比% 苯甲酸朝 0.01 蘋果酸 0.30 香料 0.1 人工增甜劑 0.05 水 差 99.5 氫氧化鈣 0.083 A7 B7 五、發明説明(15 ) 發現所生成之組合物的酸鹼値典型上爲3 8 5,且鈣對 酸的莫耳比率爲0.5。 於3 7 C下將平坦牙齒琺瑯質切面曝露於測試溶液中3 〇 錢,以進行體外測平器測試。以物理測#於該步骤間所 才貝失I琺瑯質深度,來評估腐蝕之可能性。本發明之用途 係以含有不加氫氧化鈣而使酸鹼値呈2^的控制組配方, 會導致琺瑯質有8 · 1微米的損失,而另一個已以氫氧化鈣 使酸鹼値增·加至3· 85之飲料的酸鹼値控制組配方則會損 失1.65微米,上述之組合物只移除〇 6微米琺瑯質。 -18- 本紙張尺度適用中國國家標準(CNS ) A4規格(210X 297公釐) (請先閲讀背面之注意事項再填寫本頁)
申請曰期 86. 3. 12· 案 號 86103057 類 別 ki t ^ }/b\ t以上各欄由本局填註) 592705 ~W~m 、雲!名稱 中文
姓名 人 國 修正i 一' 補充本 Α4 C4 针型專利説明書 含有鈣組成份及酸化劑之口服液態組合物及減少酸性口服組 合物之牙齒腐蝕性質的方法
atSVF〇R 〇RAL USE C0NTAINING CALCIUM COMPONENT ACIDIC 〇F TO〇TH EROSION PROPERTY OF 戴維麥特巴克 籍 英國 住、 居所 I國格洛赤夏郡柯福市皇室森林製造較韻克林貝克曼商 裝 姓么 (名稱? 國 籍 英商史密斯克林貝克曼公司 英國 線 三、申請人 英國米德莱賽劣班特福市新·# 大衛.羅伯茲 本紙張尺歧财A4規格_(ϋ297公
Claims (1)
- 第086103057號專利φ語亲592705 L 一種含有劑之口服液態組合物,其特徵 在於每莫耳酸中所存在之鈣的範圍為0,3至〇 · 5 5莫耳, 而且在組合物中鈣和酸化劑之比例係經選擇,以致使兮 組合物之酸鹼值為3. 5至4.5 〇 Λ 2·根據申請專利範圍第1項之組合物,其中每莫耳酸中所 存在之#5的範圍至少為〇·4莫耳。 3·根據申請專利範圍第丨或2項之組合物,其中該組合物之 酸鹼值不高於4。 .4.根據申請專利範圍第3項之組合物,其中酸鹼值為3 · 7至 子 3 · 9 〇 土 I 5·根據申請專利範圍第1項之組合物,其中該酸是檸檬酸 Τ 或韻果酸或乳酸或其混合物。 | 6·根據申請專利範圍第1項之組合物,其中該鈣化合物是 | 碳酸每、氫氧化鈣、檸檬酸鈣、蘋果酸鈣、乳酸鈣、氯 ί: 化鈣、甘油磷酸鈣或甲酸鈣。 ^ 7,根據申請專利範圍第1項之組合物,其係為飲料。 f:8·根據申請專利範圍第7項之組合物,其中該飲料是不起 ;; 泡沐的果汁飲料,或碳酸化清涼飲料,或較佳為保健飲 •根據申請專利範圍第8項之組合物,其中該保健飲料為 ^醋栗果汁飲料或添加維生素的飲料。 10·根據申請專利範圍第1項之組合物,其係為製備飲料之 飲料濃縮物。 1L根據申請專利範圍第1 0項之組合物’其係為果汁飲料或裝 訂保健飲料之濃縮物。 12·根據申請專利範圍第1項之組合物,其係為口服保健组 合物。 、 13·根據申請專利範圍第12項之組合物,其係為漱口水。 14· 一種減少酸性口服組合物之牙齒腐蝕性質之方法,其包 括添加鈣化合物至該酸性液態口服組合物中,使得每= 耳酸中所存在之鈣的範圍為〇·3至〇·8莫耳,而若有需要 或必要下,則藉由添加一種鹼調整該酸鹼值,以使得該 組合物之酸鹼值為3 · 5至4 · 5 ;但當該組合物為水果含量 為2 5至1 〇 〇重量百分比且酸含量至少為5克/公升(以酒 石酸計)之含水果液體時,該組合物含有少於2克〆公升 之溶解的鱗酸_。 15· —種減少酸性口服組合物之牙齒腐蝕性質之方法,其包 括添加鈣化合物至該酸性液態口服組合物中,使得每莫 耳酸中所存在之鈣的範圍為〇·3至〇·55莫耳,而若有需 要或必要下,則藉由添加一種鹼調整該酸鹼值,以使得 該組合物之酸鹼值為3 . 5至4.5。 16·根據申請專利範圍第14 5項之方法,其中每莫耳酸 中所存在之鈣的量至少為0.4莫耳。 Π·根據申請專利範圍第1 6項之方法’其中該組合物之酸驗 值不高於4。 18·根據申請專利範圍第17項之方法,其中酸鹼值為3 ·7 Α8 Β8態組合物是天然果汁飲科濃縮物。 20· —種製備根據申社 、、 艨申叫專利範圍第1至13項中任一項組合物 之方法’並白» . 〜Γ 添加鈣化合物至酸性液態口服組合物 使得每莫耳酸中所存在之鈣的範圍為0.3至0.Η莫 耳而右而要或必要下,則藉由添加一種鹼調整該酸鹼 值,以使得該組合物之酸驗值為3 .5至4.5。 21·根據申請專利範圍第2 0項之方法,其中該酸性液態組合 物是天然果汁飲料濃縮物。本紙張尺度適用中國國家標準((:^8) Α4規格(210X297公釐)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9603518.3A GB9603518D0 (en) | 1996-02-20 | 1996-02-20 | Novel process |
Publications (1)
Publication Number | Publication Date |
---|---|
TW592705B true TW592705B (en) | 2004-06-21 |
Family
ID=10789057
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW086103057A TW592705B (en) | 1996-02-20 | 1997-03-12 | Liquid composition for oral use containing calcium component and acidulant and method of reducing tooth erosion property of acidic oral composition |
Country Status (39)
Country | Link |
---|---|
US (4) | US6319490B1 (zh) |
EP (2) | EP1382263B1 (zh) |
JP (2) | JPH11507842A (zh) |
KR (1) | KR100301344B1 (zh) |
CN (1) | CN1149021C (zh) |
AP (1) | AP1184A (zh) |
AR (1) | AR005910A1 (zh) |
AT (2) | ATE339115T1 (zh) |
AU (1) | AU719631B2 (zh) |
BG (1) | BG64364B1 (zh) |
BR (1) | BR9707618A (zh) |
CA (1) | CA2247114C (zh) |
CH (1) | CH690815A5 (zh) |
CY (2) | CY2511B1 (zh) |
CZ (1) | CZ297770B6 (zh) |
DE (3) | DE69736683T2 (zh) |
DK (2) | DK0874558T3 (zh) |
EA (2) | EA002852B1 (zh) |
ES (2) | ES2208873T3 (zh) |
FI (1) | FI981781A0 (zh) |
GB (2) | GB9603518D0 (zh) |
HU (1) | HU225033B1 (zh) |
IL (1) | IL125725A (zh) |
LU (1) | LU90276B1 (zh) |
MY (1) | MY121660A (zh) |
NO (2) | NO316205B1 (zh) |
NZ (1) | NZ331363A (zh) |
PL (2) | PL191418B1 (zh) |
PT (2) | PT1382263E (zh) |
RO (1) | RO121001B1 (zh) |
SA (1) | SA97180011B1 (zh) |
SE (2) | SE521489C2 (zh) |
SI (1) | SI9720017B (zh) |
SK (1) | SK285049B6 (zh) |
TR (1) | TR199801623T2 (zh) |
TW (1) | TW592705B (zh) |
UA (1) | UA61903C2 (zh) |
WO (1) | WO1997030601A1 (zh) |
ZA (1) | ZA971358B (zh) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9603518D0 (en) * | 1996-02-20 | 1996-04-17 | Smithkline Beecham Plc | Novel process |
GB9717598D0 (en) * | 1997-08-19 | 1997-10-22 | Smithkline Beecham Plc | Novel composition and use |
GB9819530D0 (en) | 1998-09-09 | 1998-10-28 | Smithkline Beecham Plc | Novel compositions and use |
PT1140001E (pt) * | 1998-12-18 | 2005-09-30 | Palladin Healthcare Internat L | Composicao para tratamento de queimaduras |
US6071500A (en) * | 1999-01-19 | 2000-06-06 | Thistle; Robert H. | Breath spray with tooth decay and halitosis prevention characteristics |
JP3507722B2 (ja) * | 1999-03-11 | 2004-03-15 | サッポロホールディングス株式会社 | カルシウム含有透明清涼飲料の製造方法 |
US20040146466A1 (en) | 1999-11-12 | 2004-07-29 | The Procter & Gamble Company | Method of protecting teeth against erosion |
US10470985B2 (en) | 1999-11-12 | 2019-11-12 | The Procter & Gamble Company | Method of protecting teeth against erosion |
US6685920B2 (en) | 1999-11-12 | 2004-02-03 | The Procter & Gamble Company | Method of protecting teeth against erosion |
AU782649B2 (en) * | 1999-12-22 | 2005-08-18 | Wisconsin Alumni Research Foundation | Calcium formate for use as a phosphorus binder and a dietary supplement |
US6160016A (en) | 1999-12-22 | 2000-12-12 | Wisconsin Alumni Research Foundation | Phosphorus binder |
US6447754B1 (en) * | 2000-01-24 | 2002-09-10 | Akpharma Inc. | Oral rinse methods and compositions |
GB0007421D0 (en) * | 2000-03-27 | 2000-05-17 | Smithkline Beecham Plc | Novel use |
AUPQ660700A0 (en) | 2000-03-31 | 2000-05-04 | Australian Food Industry Science Centre | Calcium fortification of milk |
GB0018849D0 (en) * | 2000-08-01 | 2000-09-20 | Smithkline Beecham Plc | Novel composition and use |
US6610277B2 (en) * | 2000-12-27 | 2003-08-26 | Arthur Zuckerman | Appetite suppressant toothpaste |
US6485710B2 (en) * | 2000-12-27 | 2002-11-26 | Arthur Zuckerman | Appetite suppressant toothpaste |
ES2576404T3 (es) | 2001-09-21 | 2016-07-07 | Purac Biochem B.V. | Procedimiento para el enriquecimiento con calcio de un producto alimenticio a base de fruta |
EP1295536A1 (en) * | 2001-09-21 | 2003-03-26 | Purac Biochem B.V. | Process for the fortification of a fruit based food product with calcium |
JP4540318B2 (ja) * | 2002-08-28 | 2010-09-08 | メルシャン株式会社 | サイトカイン産生促進剤 |
EP1657984A1 (en) * | 2003-07-31 | 2006-05-24 | Shannon Minerals Ltd. | Ready-to-drink formulation containing an active ingredient |
US20050100637A1 (en) * | 2003-11-12 | 2005-05-12 | Robert Murray | Carbohydrate and electrolyte replacement composition |
US7422761B2 (en) * | 2003-12-03 | 2008-09-09 | Tropicana Products, Inc. | In-line process for preparing calcium-supplemented juice beverages |
US7208126B2 (en) * | 2004-03-19 | 2007-04-24 | E. I. Du Pont De Nemours And Company | Titanium dioxide nanopowder manufacturing process |
JP2008507480A (ja) | 2004-07-23 | 2008-03-13 | トムス グルッペン エー/エス | 唾液中における浸食可能性のない酸性固形口腔用組成物および唾液中の浸食可能性を測定する方法 |
EP1625877A3 (en) | 2004-08-09 | 2006-03-08 | Friesland Brands B.V. | Functional milk fraction |
EP2368601A3 (en) * | 2004-09-29 | 2012-03-07 | Rejuvedent, LLC | A tooth rejuvenation composition, a capsule and an applicator for rejuvenating treatment of hard tissue |
US20080280260A1 (en) * | 2004-09-29 | 2008-11-13 | Belikov Andrei V | Method and Apparatus for Tooth Rejuvenation and Hard Tissue Modification |
GB0506015D0 (en) * | 2005-03-23 | 2005-04-27 | Glaxo Group Ltd | Novel use |
WO2006118090A1 (ja) | 2005-04-28 | 2006-11-09 | Taiyokagaku Co., Ltd. | 含水食品 |
US20070077314A1 (en) | 2005-07-15 | 2007-04-05 | Pak Charles Y C | Powder mix of potassium calcium citrate for the treatment of kidney stones and osteoporosis |
US20070172569A1 (en) * | 2006-01-25 | 2007-07-26 | Chang Pei K | Stable cola flavor emulsion and method |
KR20080098616A (ko) * | 2006-02-21 | 2008-11-11 | 뉴트리조이, 인크. | 향상된 맛을 지닌 단백질 함유 식품 또는 음료를 제조하기 위한 조성 및 제조 방법 및 칼슘과 미량 광물질로 영양 보충된 과일 주스 |
NL1031439C2 (nl) * | 2006-03-24 | 2007-09-25 | Friesland Brands Bv | Zuursensatie verhogend middel, alsmede een werkwijze voor het verhogen van de zuursensatie, en vruchtensap houdende dranken met daarin het zuursensatie verhogend middel. |
EA009816B1 (ru) * | 2006-05-23 | 2008-04-28 | Товарищество С Ограниченной Ответственностью «Центр Медицинских Технологий "Infra Ks"» | Способ получения кальцийсодержащей биологически активной добавки |
US20090087539A1 (en) * | 2007-10-01 | 2009-04-02 | Fry Ross G | Sustained energy drink |
GB0723519D0 (en) * | 2007-11-30 | 2008-01-09 | Glaxo Group Ltd | Novel use |
US20090162490A1 (en) * | 2007-12-20 | 2009-06-25 | Tropicana Products, Inc. | Calcium-fortified beverages and method of making thereof |
US8435590B2 (en) * | 2008-11-24 | 2013-05-07 | Stokely-Van Camp, Inc. | Use of novel carbohydrates and carbohydrate blends to provide a sports beverage with increased absorption |
JP2010200706A (ja) * | 2009-03-05 | 2010-09-16 | Shiraishi Kogyo Kaisha Ltd | カルシウム強化炭酸飲料の製造方法 |
AU2010292276B2 (en) | 2009-09-11 | 2014-07-17 | The Procter & Gamble Company | Methods and compositions for hydrophobic modification of oral cavity surfaces |
US8293299B2 (en) | 2009-09-11 | 2012-10-23 | Kraft Foods Global Brands Llc | Containers and methods for dispensing multiple doses of a concentrated liquid, and shelf stable Concentrated liquids |
US20110064859A1 (en) * | 2009-09-17 | 2011-03-17 | Conopco, Inc., D/B/A Unilever | Frozen confection |
WO2011045130A1 (en) | 2009-10-15 | 2011-04-21 | Unilever Plc | Tooth-friendly food products |
US20110135791A1 (en) * | 2009-12-07 | 2011-06-09 | The Coca-Cola Company | Concentrate composition for providing edible calcium-fortified products using stabilized buffering protein component |
US11013248B2 (en) | 2012-05-25 | 2021-05-25 | Kraft Foods Group Brands Llc | Shelf stable, concentrated, liquid flavorings and methods of preparing beverages with the concentrated liquid flavorings |
US10123953B2 (en) | 2012-06-21 | 2018-11-13 | The Procter & Gamble Company | Reduction of tooth staining derived from cationic antimicrobials |
JP2015092834A (ja) * | 2013-11-08 | 2015-05-18 | ハウス食品株式会社 | 炭酸感を付与した経口組成物及び炭酸感付与剤 |
JP6444704B2 (ja) * | 2013-12-25 | 2018-12-26 | 花王株式会社 | 動物用デンタルケア用組成物 |
JP5689549B1 (ja) * | 2014-02-27 | 2015-03-25 | ポッカサッポロフード&ビバレッジ株式会社 | 酸性飲料 |
JP2015147798A (ja) * | 2015-04-20 | 2015-08-20 | ビーエーエスエフ ビューティ ケア ソリューションズ フランス エスエーエス | 弾性繊維の形成を刺激するための、loxl(リシルオキシダーゼ類似)アイソフォームの合成及び活性の刺激 |
NO341376B1 (no) | 2016-03-02 | 2017-10-23 | Akvadesign As | Oppdriftssystem for en merd |
DE102016215200A1 (de) * | 2016-08-16 | 2018-02-22 | Henkel Ag & Co. Kgaa | "Farbschutz-Haarbehandlungsmittel mit Erdalkalisalzen von Dicarbonsäuren" |
MD4605C1 (ro) | 2017-10-10 | 2019-06-30 | Николае Попеску | Procedee de executare a elementelor de construcţie ale clădirii/edificiului din beton armat monolit şi echipament tehnologic pentru realizarea acestora |
EP3958983A1 (en) | 2019-04-26 | 2022-03-02 | The Procter & Gamble Company | Reduction of tooth staining derived from cationic antimicrobials |
Family Cites Families (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE332342C (sv) | 1968-12-04 | 1972-11-13 | Astra Home Prod Ab | Pulverdryckblandning |
US4237147A (en) * | 1974-01-04 | 1980-12-02 | Monsanto Company | Stabilized amorphous calcium carbonate |
IE42129B1 (en) | 1974-10-10 | 1980-06-04 | Procter & Gamble | Compositions for remineralizing tooth enamel |
US4551342A (en) | 1983-02-01 | 1985-11-05 | The Procter & Gamble Company | Beverages containing specific cation-edible acid mixtures for improved flavor impression |
JPS6136211A (ja) | 1984-07-26 | 1986-02-20 | Lion Corp | 口腔用組成物 |
US4851221A (en) * | 1985-02-19 | 1989-07-25 | Mission Pharmacal Company | Liquid calcium supplementation from readily soluble mixtures of calcium compound and citric acid |
US5017362A (en) | 1985-09-13 | 1991-05-21 | Colgate-Palmolive Company | Anticalculus oral composition |
US4737375A (en) * | 1985-12-26 | 1988-04-12 | The Procter & Gamble Company | Beverages and beverage concentrates nutritionally supplemented with calcium |
US4814177A (en) * | 1986-03-18 | 1989-03-21 | Board Of Regents, University Of Texas System | Ultradense and more soluble and bioavailable preparations of calcium citrate |
US4722847A (en) * | 1986-05-07 | 1988-02-02 | The Procter & Gamble Company | Fruit juice beverages and juice concentrates nutritionally supplemented with calcium |
US5028446A (en) * | 1987-07-31 | 1991-07-02 | Kraft General Foods, Inc. | Process for making calcium beverages containing rapidly solubilized calcium fumarate |
US4830862A (en) * | 1987-07-31 | 1989-05-16 | The Procter & Gamble Company | Calcium-supplemented beverages and beverage concentrates containing low levels of sulfate |
GB2207335A (en) * | 1987-07-31 | 1989-02-01 | Procter & Gamble | Calcium-supplemented beverages and beverage concentrates containing low levels of chloride |
US5186965A (en) * | 1990-06-14 | 1993-02-16 | The Procter & Gamble Company | Calcium citrate malate composition |
JPH04139120A (ja) | 1990-09-27 | 1992-05-13 | Lion Corp | 口腔用組成物 |
US5108761A (en) * | 1990-10-01 | 1992-04-28 | The Procter & Gamble Company | Method of preventing tooth enamel erosion utilizing an acidic beverage containing calcium |
WO1992007475A1 (en) * | 1990-10-31 | 1992-05-14 | The Procter & Gamble Company | Calcium fortified sauces |
US5096701A (en) | 1990-12-18 | 1992-03-17 | The Procter & Gamble Company | Oral compositions |
ATE253921T1 (de) * | 1991-05-06 | 2003-11-15 | Procter & Gamble | Kombinationen aus calzium und vitamin d |
US5208372A (en) * | 1991-05-23 | 1993-05-04 | Kraft General Foods, Inc. | Calcium Citrate anticaking agent |
US5149552A (en) * | 1991-05-23 | 1992-09-22 | Kraft General Foods, Inc. | Calcium citrate anticaking agent |
US5219602A (en) * | 1991-12-20 | 1993-06-15 | Kraft General Foods, Inc. | Aqueous calcium citrate compositions |
US5194270A (en) * | 1991-12-20 | 1993-03-16 | Kraft General Foods, Inc. | Calcium citrate-vegetable oil compositions |
US5258190A (en) * | 1991-12-20 | 1993-11-02 | Kraft General Foods, Inc. | Calcium citrate-vegetable oil compositions |
US5270297A (en) * | 1992-07-23 | 1993-12-14 | Metagenics, Inc. | Endurance and rehydration composition |
US5223287A (en) * | 1992-08-25 | 1993-06-29 | Kraft General Foods, Inc. | Dried fruits and cereal combinations thereof |
EP0587972A1 (en) * | 1992-09-18 | 1994-03-23 | The Procter & Gamble Company | Sports drink without added sugar or artificial sweetener |
EP0665719B1 (en) * | 1992-10-21 | 1997-01-15 | The Procter & Gamble Company | Sweetener containing a concentrated bioavailable calcium source |
ATE198122T1 (de) * | 1992-10-21 | 2001-01-15 | Procter & Gamble | Konzentrierte, bioverfügbare kalziumquelle |
EP0634110A3 (en) * | 1993-07-08 | 1995-02-01 | Eckes Ag | Fluid food. |
US5424082A (en) * | 1994-03-03 | 1995-06-13 | The Proctor & Gamble Company | Calcium and vitamin C containing beverage products with improved color stability |
US5474793A (en) * | 1994-05-10 | 1995-12-12 | Meyer; Larry E. | Process for preparing calcium-supplemented not-from-concentrate fruit juice beverages |
US5500232A (en) * | 1994-10-06 | 1996-03-19 | Bristol-Myers Squibb Company | Calcium fortified beverages |
TW323330B (zh) * | 1994-10-17 | 1997-12-21 | Toshiba Co Ltd | |
ES2152514T3 (es) | 1995-02-28 | 2001-02-01 | Procter & Gamble | Preparacion de productos de bebidas no carbonatadas que tienen una estabilidad microbiana superior. |
US5855948A (en) * | 1995-03-02 | 1999-01-05 | Robinsons Soft Drinks Limited | Drink compositions utilizing gelatinised starch and method of making |
FR2731588B1 (fr) | 1995-03-16 | 1997-05-30 | Systemes Bio Ind | Composition pour la stabilisation de boissons acides |
US5817351A (en) * | 1995-04-07 | 1998-10-06 | Abbott Laboratories | Calcium fortified low pH beverage |
US5597595A (en) * | 1995-04-07 | 1997-01-28 | Abbott Laboratories | Low pH beverage fortified with calcium and vitamin D |
GB9525290D0 (en) * | 1995-12-11 | 1996-02-07 | Whittle Brian A | Nutritional compositions |
DE19604812C1 (de) | 1995-12-13 | 1996-12-12 | Hoelzl Hans | Vorrichtung und Verfahren zur automatischen Ausbringung von Düngemitteln, insbesondere von Klärschlammfrischmasse |
GB9603518D0 (en) * | 1996-02-20 | 1996-04-17 | Smithkline Beecham Plc | Novel process |
JPH09295942A (ja) | 1996-04-26 | 1997-11-18 | Koshi Ishino | 虫歯予防剤 |
US5939052A (en) | 1996-11-21 | 1999-08-17 | The Procter & Gamble Company | Dentifrice compositions containing polyphosphate and fluoride |
US6190644B1 (en) | 1996-11-21 | 2001-02-20 | The Procter & Gamble Company | Dentifrice compositions containing polyphosphate and monofluorophosphate |
US6187295B1 (en) | 1996-11-21 | 2001-02-13 | The Procter & Gamble Company | Methods of reducing the astringency of stannous in dentifrice compositions |
US5939117A (en) * | 1997-08-11 | 1999-08-17 | Mantrose-Haeuser Co., Inc. | Methods for preserving fresh fruit and product thereof |
GB9717598D0 (en) * | 1997-08-19 | 1997-10-22 | Smithkline Beecham Plc | Novel composition and use |
US6022576A (en) | 1997-10-28 | 2000-02-08 | Lipton, Division Of Conopco, Inc. | Flavoring materials for use in tea containing beverages |
GB9819530D0 (en) | 1998-09-09 | 1998-10-28 | Smithkline Beecham Plc | Novel compositions and use |
US6379586B1 (en) | 1998-10-20 | 2002-04-30 | The Boc Group, Inc. | Hydrocarbon partial oxidation process |
AU5891000A (en) | 1999-06-28 | 2001-01-31 | Astaris Llc | Non-carbonated beverages comprising antimicrobial long chain polyphosphates |
US6261610B1 (en) * | 1999-09-24 | 2001-07-17 | Nestec S.A. | Calcium-magnesium fortified water, juices, beverages and other liquid food products and process of making |
US9585827B2 (en) | 2000-01-21 | 2017-03-07 | The Procter & Gamble Company | Kits comprising a beverage composition and information for use |
-
1996
- 1996-02-20 GB GBGB9603518.3A patent/GB9603518D0/en active Pending
-
1997
- 1997-02-12 DE DE69736683T patent/DE69736683T2/de not_active Expired - Lifetime
- 1997-02-12 PT PT03078087T patent/PT1382263E/pt unknown
- 1997-02-12 AU AU18725/97A patent/AU719631B2/en not_active Ceased
- 1997-02-12 RO RO98-01307A patent/RO121001B1/ro unknown
- 1997-02-12 DK DK97905013T patent/DK0874558T3/da active
- 1997-02-12 CA CA002247114A patent/CA2247114C/en not_active Expired - Fee Related
- 1997-02-12 CN CNB971923760A patent/CN1149021C/zh not_active Expired - Fee Related
- 1997-02-12 US US09/125,471 patent/US6319490B1/en not_active Expired - Fee Related
- 1997-02-12 NZ NZ331363A patent/NZ331363A/xx not_active IP Right Cessation
- 1997-02-12 TR TR1998/01623T patent/TR199801623T2/xx unknown
- 1997-02-12 IL IL12572597A patent/IL125725A/xx not_active IP Right Cessation
- 1997-02-12 PL PL357119A patent/PL191418B1/pl unknown
- 1997-02-12 SI SI9720017A patent/SI9720017B/sl not_active IP Right Cessation
- 1997-02-12 AT AT03078087T patent/ATE339115T1/de active
- 1997-02-12 HU HU9900998A patent/HU225033B1/hu not_active IP Right Cessation
- 1997-02-12 DE DE69725556T patent/DE69725556T2/de not_active Expired - Lifetime
- 1997-02-12 DK DK03078087T patent/DK1382263T3/da active
- 1997-02-12 EA EA200000954A patent/EA002852B1/ru not_active IP Right Cessation
- 1997-02-12 US US09/125,471 patent/US20010043908A1/en active Granted
- 1997-02-12 BR BR9707618A patent/BR9707618A/pt not_active IP Right Cessation
- 1997-02-12 GB GB9817698A patent/GB2326596B/en not_active Expired - Lifetime
- 1997-02-12 EA EA199800646A patent/EA001375B1/ru not_active IP Right Cessation
- 1997-02-12 AT AT97905013T patent/ATE251853T1/de active
- 1997-02-12 DE DE19781601T patent/DE19781601T1/de not_active Ceased
- 1997-02-12 JP JP9529757A patent/JPH11507842A/ja active Pending
- 1997-02-12 CH CH01772/98A patent/CH690815A5/de not_active IP Right Cessation
- 1997-02-12 AP APAP/P/1998/001324A patent/AP1184A/en active
- 1997-02-12 ES ES97905013T patent/ES2208873T3/es not_active Expired - Lifetime
- 1997-02-12 SK SK1128-98A patent/SK285049B6/sk not_active IP Right Cessation
- 1997-02-12 EP EP03078087A patent/EP1382263B1/en not_active Expired - Lifetime
- 1997-02-12 EP EP97905013A patent/EP0874558B8/en not_active Expired - Lifetime
- 1997-02-12 WO PCT/EP1997/000646 patent/WO1997030601A1/en active IP Right Grant
- 1997-02-12 KR KR1019980706475A patent/KR100301344B1/ko not_active IP Right Cessation
- 1997-02-12 ES ES03078087T patent/ES2272887T3/es not_active Expired - Lifetime
- 1997-02-12 CZ CZ0265398A patent/CZ297770B6/cs not_active IP Right Cessation
- 1997-02-12 PL PL97328472A patent/PL185645B1/pl unknown
- 1997-02-12 PT PT97905013T patent/PT874558E/pt unknown
- 1997-02-18 MY MYPI97000588A patent/MY121660A/en unknown
- 1997-02-18 ZA ZA9701358A patent/ZA971358B/xx unknown
- 1997-02-19 AR ARP970100661A patent/AR005910A1/es active IP Right Grant
- 1997-03-12 TW TW086103057A patent/TW592705B/zh not_active IP Right Cessation
- 1997-05-11 SA SA97180011A patent/SA97180011B1/ar unknown
- 1997-12-02 UA UA98084407A patent/UA61903C2/uk unknown
-
1998
- 1998-08-19 FI FI981781A patent/FI981781A0/fi not_active Application Discontinuation
- 1998-08-19 LU LU90276A patent/LU90276B1/fr active
- 1998-08-19 SE SE9802763A patent/SE521489C2/sv not_active IP Right Cessation
- 1998-08-19 BG BG102702A patent/BG64364B1/bg unknown
- 1998-08-19 NO NO19983798A patent/NO316205B1/no not_active IP Right Cessation
-
2001
- 2001-10-16 US US09/978,993 patent/US6719963B2/en not_active Expired - Fee Related
-
2003
- 2003-07-09 SE SE0302033A patent/SE526779C2/sv not_active IP Right Cessation
- 2003-09-09 NO NO20033984A patent/NO317809B1/no not_active IP Right Cessation
- 2003-12-10 US US10/733,992 patent/US6908909B2/en not_active Expired - Fee Related
-
2004
- 2004-03-03 JP JP2004059396A patent/JP2004196819A/ja not_active Withdrawn
-
2005
- 2005-04-12 CY CY0500022A patent/CY2511B1/xx unknown
-
2007
- 2007-07-11 CY CY0700012A patent/CY2577B1/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW592705B (en) | Liquid composition for oral use containing calcium component and acidulant and method of reducing tooth erosion property of acidic oral composition | |
Tahmassebi et al. | Soft drinks and dental health: a review of the current literature | |
TWI243685B (en) | Acidic composition for oral administration and its uses | |
TWI274554B (en) | An orally administrable acidic composition for reducing the tooth erosion caused by acid in orally administrable acidic compositions | |
AU2001252227A1 (en) | Use of polyphosphate as a tooth erosion inhibitor in acidic compositions | |
US10660832B2 (en) | Acidic solid oral compositions without erosive potential in saliva and method for determining erosive potential in saliva | |
WO2007103110A2 (en) | Reduction of the titratable acidity and the prevention of tooth and other bone degeneration | |
JP2009173650A (ja) | 有機酸による歯のエナメル質の溶解が阻害される口腔用組成物 | |
WO2009068600A1 (en) | Compositions for reducing dental erosion | |
MXPA98006724A (en) | Liquid oral compositions comprising a compound of calcium and acidula | |
JP2019142781A (ja) | 酒酔い対策用組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |